Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Science

• Publication date

  1992-02-07

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1126/SCIENCE.1738846PMID 1738846
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cells.

  1991cited by this paper
• The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway.

  1990cited by this paper
• Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing.

  1990cited by this paper
• Cleavage of amyloid beta peptide during constitutive processing of its precursor.

  1990cited by this paper
• Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation.

  1990cited by this paper
• Formation of amyloid-like fibrils in COS cells overexpressing part of the Alzheimer amyloid protein precursor

  1990cited by this paper
• Identification and characterization of C‐terminal fragments of the beta‐amyloid precursor produced in cell culture.

  1990cited by this paper
• Soluble derivatives of the β amyloid protein precursor of Alzheimer's disease are labeled by antisera to the β amyloid protein

  1989cited by this paper
• Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease.

  1989cited by this paper
• Characterization of an amyloid beta precursor protein that binds heparin and contains tyrosine sulfate.

  1989cited by this paper
• The beta-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid.

  1989cited by this paper
• Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein.

  1989cited by this paper
• Soluble derivatives of the beta amyloid protein precursor of Alzheimer's disease are labeled by antisera to the beta amyloid protein.

  1989cited by this paper
• Use of an Epstein-Barr virus episomal replicon for anti-sense RNA-mediated gene inhibition in a human cytotoxic T-cell clone.

  1988cited by this paper
• Phosphorylation of Alzheimer disease amyloid precursor peptide by protein kinase C and Ca2+/calmodulin-dependent protein kinase II.

  1988cited by this paper
• Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease.

  1988cited by this paper
• Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues.

  1988cited by this paper
• Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.

  1987cited by this paper

• Targeting the PS1-ELK1 protein-protein interaction with a peptide-based inhibitor reduces Aβ production and alleviates memory decline in Alzheimer's disease.

  2025cites this paper
• ELK1 inhibition alleviates amyloid pathology and memory decline by promoting the SYVN1-mediated ubiquitination and degradation of PS1 in Alzheimer’s disease

  2025cites this paper
• REELIN ameliorates Alzheimer's disease, but how?

  2024cites this paper
• Fangchinoline alleviates cognitive impairments through enhancing autophagy and mitigating oxidative stress in Alzheimer’s disease models

  2023cites this paper
• The role of O-GlcNAcation in neurodevelopment and nerve system diseases

  2022cites this paper
• Proteinopathies: Deciphering Physiology and Mechanisms to Develop Effective Therapies for Neurodegenerative Diseases

  2022cites this paper
• Amyloid-beta peptide induces oligodendrocyte death by activating Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway the neutral sphingomyelinase-ceramide pathway

  2022cites this paper
• The Implication of Glial Metabotropic Glutamate Receptors in Alzheimer’s Disease

  2021cites this paper
• Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies

  2020cites this paper
• Glucose transporters in brain in health and disease

  2020influential citation
• Non-specific Detection of a Major Western Blotting Band in Human Brain Homogenates by a Multitude of Amyloid Precursor Protein Antibodies

  2019cites this paper
• BiochemiCaI studies in Alzheimer's disease: the APParent diagnostic and therapeutic role of antipsychotics on calcium homeostasis and amyloid-precursor-protein metabolism

  2019cites this paper
• Losing connections in Alzheimer disease : the amyloid precursor protein processing machinery at the synapse

  2018cites this paper
• Membrane Dynamics of γ-Secretase Provides a Molecular Basis for β-Amyloid Binding and Processing.

  2017cites this paper
• Cryo-EM structures of human γ-secretase.

  2017cites this paper
• O-GlcNAcylation and neurodegeneration.

  2017cites this paper
• Membrane Dynamics of γ-Secretase Provides a Molecular Basis for β-Amyloid Binding and Processing.

  2017cites this paper
• Dominant negative effect of the loss-of-function γ-secretase mutants on the wild-type enzyme through heterooligomerization

  2017cites this paper
• Title : Alzheimer ’ s disease pathogenesis is dependent on neuronal receptor PTP σ

  2016influential citation
• Brain ischemia with Alzheimer phenotype dysregulates Alzheimer’s disease-related proteins

  2016cites this paper
• The Role of Reelin Signaling in Alzheimer’s Disease

  2016cites this paper
• Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma

  2016cites this paper
• Inhibition of death-associated protein kinase 1 attenuates the phosphorylation and amyloidogenic processing of amyloid precursor protein.

  2016cites this paper
• Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase

  2016cites this paper
• Alzheimer-related pathogenesis is dependent on neuronal receptor PTPσ

  2016cites this paper
• Intracellular and extracellular O-linked N-acetylglucosamine in the nervous system.

  2015cites this paper
• η-Secretase processing of APP inhibits neuronal activity in the hippocampus

  2015cites this paper
• The Emerging Link between O-GlcNAc and Alzheimer Disease*

  2014cites this paper
• Activation of TRPML1 Clears Intraneuronal Aβ in Preclinical Models of HIV Infection

  2014cites this paper
• Secreted Amyloid β-Proteins in a Cell Culture Model Include N-Terminally Extended Peptides That Impair Synaptic Plasticity

  2014cites this paper
• O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond.

  2014cites this paper
• Immunity, Tumors and Aging: The Role of HSP70

  2013cites this paper
• Development of functional tools to study the role of O-GlcNAc in tau biology

  2013cites this paper
• Regulation of apolipoprotein E secretion, lipidation and recycling in the central nervous system

  2013influential citation
• Molecular Pathology of Alzheimer's Disease

  2013cites this paper
• Investigating Organic Nitrate Tolerance and Alzheimer's Disease: Roles for Aldehyde Dehydrogenase 2 and 4-Hydroxynonenal

  2013cites this paper
• The Role of HSP70 in the Protection of: (A) The Brain in Alzheimer’s Disease and (B) The Heart in Cardiac Surgery

  2013cites this paper
• Alzheimer's factors in postischemic dementia.

  2012cites this paper
• Neuronal β-amyloid generation is independent of lipid raft association of β-secretase BACE1: analysis with a palmitoylation-deficient mutant

  2012cites this paper
• AGE DEPENDENT ΒETA-AMYLOID ISOFORMS AND IMPLICATIONS OF DIFFERENT DRUG TREATMENTS AS STUDIED IN DIFFERENT TRANSGENIC MOUSE MODELS AND CELL LINES

  2012cites this paper
• Tau and Amyloid- Conformational Change to -Sheet Structures as Effectors in the Development of Alzheimer's Disease

  2012cites this paper
• Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-β peptide in mice.

  2011cites this paper
• Intracellular trafficking of the β‐secretase and processing of amyloid precursor protein

  2011cites this paper
• Multilingualism and the risk of Alzheimer disease and dementia

  2011cites this paper
• Reelin-mediated Signaling during Normal and Pathological Forms of Aging.

  2010cites this paper
• Targeted hydrolysis of Beta-amyloid with engineered antibody fragment.

  2010cites this paper
• Reduced Reelin Expression Accelerates Amyloid-β Plaque Formation and Tau Pathology in Transgenic Alzheimer's Disease Mice

  2010cites this paper
• Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases.

  2010cites this paper
• Lecithin and choline in human health and disease.

  2009cites this paper
• Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology.

  2009cites this paper
• Different protection of K252a and N‐acetyl‐L‐cysteine against amyloid‐β peptide–induced cortical neuron apoptosis involving inhibition of MLK3–MKK7–JNK3 signal cascades

  2009cites this paper
• Oxidative stress induces macroautophagy of amyloid beta-protein and ensuing apoptosis.

  2009cites this paper
• Brain cathepsin B but not metalloendopeptidases degrade rAPP751 with production of amyloidogenic fragments. Comparison with synthetic peptides emulating beta- and gamma-secretase sites.

  2009cites this paper
• Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model.

  2009cites this paper
• Analyse des neuen Proteins TMEM59 und seiner Funktion in dem Transport und der Prozessierung des Amyloid-Vorläufer-Proteins

  2008cites this paper
• Molecular genetics of Alzheimer's disease: An update

  2008cites this paper
• The role of exosomes in the processing of proteins associated with neurodegenerative diseases

  2008cites this paper
• Beta-secretase: structure, function, and evolution.

  2008cites this paper
• Development of Alzheimer's disease imaging agents for clinical studies.

  2008cites this paper
• Introspective analysis of amyloid as the cause of Alzheimer’s disease: alternative model proposed

  2008cites this paper
• Molecular biology of Alzheimer's amyloid—Dutch variant

  2008cites this paper
• Chaperone signalling complexes in Alzheimer's disease

  2008cites this paper
• Aging and Alzheimer's Disease

  2007cites this paper
• Chapter 1 Amyloid and Amyloid-Like Protein Aggregates in Neurodegenerative Disease

  2007cites this paper
• Isoform Specific Amyloid-β Protein Precursor Metabolism

  2007cites this paper
• Isoform specific amyloid-beta protein precursor metabolism.

  2007cites this paper
• Differential effect of tacrine and physostigmine on the secretion of the β-amyloid precursor protein in cell lines

  2007cites this paper
• Intracellular pH regulates amyloid precursor protein intracellular domain accumulation.

  2007cites this paper
• The Function of the Amyloid Precursor Protein Family

  2007cites this paper
• Is the LDL Receptor Involved in Cortical Amyloid Protein Clearance?

  2006cites this paper
• Amyloid β and neuromelanin-Toxic or protective molecules?. The cellular context makes the difference

  2006cites this paper
• Pathogenesis of Alzheimer's Dementia

  2006cites this paper
• Apple Phenolics and Alzheimer's Disease

  2005cites this paper
• Altered intracellular signaling and reduced viability of Alzheimer's disease neuronal cybrids is reproduced by beta-amyloid peptide acting through receptor for advanced glycation end products (RAGE).

  2005cites this paper
• Sodium azide and 2-deoxy-D-glucose-induced cellular stress affects phosphorylation-dependent AβPP processing

  2005cites this paper
• Pathophysiological roles of amyloidogenic carboxy-terminal fragments of the beta-amyloid precursor protein in Alzheimer's disease.

  2005cites this paper
• Extracellular release of BACE1 holoproteins from human neuronal cells.

  2005cites this paper
• Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway.

  2004cites this paper
• Efficient 3D Database Screening for Novel HIV-1 IN Inhibitors

  2004cites this paper
• Senile plaques do not progressively accumulate with normal aging

  2004cites this paper
• Cholesterol and Alzheimer's disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factors.

  2004cites this paper
• Glypican-1 as an Abeta binding HSPG in the human brain: its localization in DIG domains and possible roles in the pathogenesis of Alzheimer's disease.

  2004cites this paper
• Glypican‐1 as an Aβ binding HSPG in the human brain: Its localization in DIG domains and possible roles in the pathogenesis of Alzheimer's disease

  2004cites this paper
• Amino-truncated amyloid beta-peptide (Abeta5-40/42) produced from caspase-cleaved amyloid precursor protein is deposited in Alzheimer's disease brain.

  2004cites this paper
• Amino‐truncated amyloid β‐peptide (Aβ5‐40/42) produced from caspase‐cleaved amyloid precursor protein is deposited in Alzheimer’s disease brain

  2004cites this paper
• Neutral sphingomyelinase activation in endothelial and glial cell death induced by amyloid beta-peptide.

  2004cites this paper
• Prediction of HIV-1 integrase/viral DNA interactions in the catalytic domain by fast molecular docking.

  2004cites this paper
• Amyloid- (cid:2) peptide induces oligodendrocyte death by activating the neutral sphingomyelinase– ceramide pathway

  2003cites this paper
• Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets

  2003cites this paper
• Amyloid‐beta increases acetylcholinesterase expression in neuroblastoma cells by reducing enzyme degradation

  2003cites this paper
• Astroglial expression of the beta-amyloid in ischemia-reperfusion brain injury.

  2002cites this paper
• N-methyl-d-aspartate receptor-mediated processing of beta-amyloid precursor protein in rat hippocampal slices: in vitro--superfusion study.

  2002cites this paper
• Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease.

  2002cites this paper
• Tyrosine Phosphorylation of the β-Amyloid Precursor Protein Cytoplasmic Tail Promotes Interaction with Shc*

  2002cites this paper
• Amyloid Precursor Protein, Presenilins, and α-Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease

  2002cites this paper
• Cortico‐hippocampal APP and NGF levels are dynamically altered by cholinergic muscarinic antagonist or M1 agonist treatment in normal mice

  2002cites this paper
• Colostrinin ® : a Proline-Rich Polypeptide ( PRP ) Complex Isolated from Ovine Colostrum for Treatment of Alzheimer ’ s Disease . A Double-Blind , Placebo-Controlled Study

  2002cites this paper
• Signal Transduction through Tyrosine-phosphorylated C-terminal Fragments of Amyloid Precursor Protein via an Enhanced Interaction with Shc/Grb2 Adaptor Proteins in Reactive Astrocytes of Alzheimer's Disease Brain*

  2002cites this paper
• Effect of tumor necrosis factor‐α converting enzyme (TACE) and metalloprotease inhibitor on amyloid precursor protein metabolism in human neurons

  2002cites this paper
• Cholinergic abnormalities in Alzheimer's disease: are there new targets for drug development?

  2002cites this paper